Search
for

    Sort by

    Research 91–120 of 1000+

    1. Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry Journal of Endocrinology and Metabolism · 2025
    2. Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry bioRxiv (Cold Spring Harbor Laboratory) · 2024
    3. Pharmacokinetics of two different formulations of finasteride (topical and oral) in male volunteers with androgeneic alopecia 2013
    4. (192) Evaluating Effect of hCG and hCG+rFSH Therapy on Ejaculation Disorders in Middle-Aged Men: A Case Study ˜The œjournal of sexual medicine · 2024
    5. Adverse effects of the 5-alpha-reductase inhibitor finasteride on Daphnia magna: Endocrine system and lipid metabolism disruption Ecotoxicology and Environmental Safety · 2024
    6. Determinants of Plasma Androgen and Estrogen Levels in Men Data Archiving and Networked Services (DANS) · 2006
    7. Finasteride Drugs · 1999 · 40 citations
    8. Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase. PubMed · 2005 · 38 citations
    9. Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects The Journal of Sexual Medicine · 2012 · 35 citations
    10. Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia Expert Opinion on Investigational Drugs · 1999 · 32 citations
    11. Complications of Subcutaneous Contraception: A Review Curēus · 2018 · 27 citations
    12. New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men Advances in Clinical Chemistry · 2018 · 14 citations
    13. Current treatment of BPH Biomedicine & pharmacotherapy · 1995 · 11 citations
    14. Assessing dutasteride-associated sexual dysfunction using the U.S. Food and Drug Administration Adverse Event Reporting System Journal of the European Academy of Dermatology and Venereology · 2017 · 7 citations
    15. Impact of Hormones on Female Sexual Function and Dysfunction Female pelvic medicine & reconstructive surgery · 2011 · 3 citations
    16. Finasteride in Androgenic Alopecia Journal of the Dermatology Nurses’ Association · 2016 · 1 citations
    17. Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance Pharmaceuticals · 2026
    18. P166 Real-world efficacy and tolerability of oral dutasteride combined with oral minoxidil for male androgenetic alopecia: a retrospective cohort study British Journal of Dermatology · 2026
    19. Impact of 5-alpha Reductase Inhibitors on Male Reproductive Health: A Review of Finasteride and Dutasteride. PubMed · 2026
    20. Male androgenetic alopecia Anais Brasileiros de Dermatologia · 2025
    21. Post‐finasteride syndrome: real or myth? Trends in Urology & Men s Health · 2024
    22. Treatment of hyperestrogenism in men of fertile age with testicular testosterone deficit INSTITUTIONAL REPOSITORY OF ODESSA NATIONAL UNIVERSITY NAMED I.I. Mechnykova (Odesa I.I.Mechnikov National University) · 2024
    23. Hypoactive Sexual Desire and Other Sexual Dysfunctions Caused by Side Effects of Medicines Used to Treat Various Somatic Diseases and for Contraception Zdorov'â čolovìka · 2023
    24. Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach DOAJ (DOAJ: Directory of Open Access Journals) · 2018
    25. 5α‐Reductase Inhibitors 2014
    26. Notes from the Editor Emeritus: Medical therapy for hair loss: what we know and what we need to find out Hair transplant forum international · 2013
    27. Finasteride 2004
    28. Hair disorders update: Alopecia to hirsutism Current problems in dermatology · 2000
    29. PROGRESSIVE SLEEP APNOEAS RESPOND TO MEDROXYPROGESTERONE ACETATE Inpharma (Balgowlah) · 1981
    30. [Therapy of androgenetic alopecia with finasteride. What must be considered in consultation and drug prescribing]. PubMed · 1999